Literature DB >> 25492930

The INPULSIS enigma: exacerbations in idiopathic pulmonary fibrosis.

Samy Suissa1, Pierre Ernst1.   

Abstract

Entities:  

Keywords:  Clinical Epidemiology; Idiopathic pulmonary fibrosis

Mesh：

Substances：

Year:  2014        PMID： 25492930     DOI： 10.1136/thoraxjnl-2014-206598

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  3 in total

1.  Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration.

Authors:  Satoshi Ikeda; Akimasa Sekine; Tomohisa Baba; Terufumi Kato; Takuma Katano; Erina Tabata; Ryota Shintani; Hideaki Yamakawa; Tsuneyuki Oda; Ryo Okuda; Hideya Kitamura; Tae Iwasawa; Tamiko Takemura; Takashi Ogura
Journal:  Medicine (Baltimore)       Date:  2022-06-03       Impact factor: 1.817

2.  Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report.

Authors:  Satoshi Ikeda; Akimasa Sekine; Tomohisa Baba; Hideaki Yamakawa; Masato Morita; Hideya Kitamura; Takashi Ogura
Journal:  BMC Pulm Med       Date:  2016-03-03       Impact factor: 3.317

3.  Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports.

Authors:  Satoshi Okamori; Takanori Asakura; Keita Masuzawa; Hiroyuki Yasuda; Hirofumi Kamata; Makoto Ishii; Tomoko Betsuyaku
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.